Ads
related to: vertex pharmaceuticals- Our Company
Learn about our mission and
the values that drive us.
- Contact Us
Find all the ways to reach us
for the information you need.
- News
Stay current on all things Vertex
and discover the latest news.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- Our Company
Search results
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 20 hours agoVertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks....
Vertex Pharmaceuticals (VRTX) to Release Earnings on Monday
ETF DAILY NEWS· 3 days agoVertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) will be announcing its earnings results after the market closes on Monday, May 6th. Analysts expect ...
Unveiling Vertex (VRTX) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks· 1 day agoFree Report) to post quarterly earnings of $4.10 per share in its upcoming report, which indicates a year-over-year increase of 34.4%. The current level reflects an upward revision of 0.4% in ...
Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know
Zacks via Yahoo Finance· 6 days agoVertex Pharmaceuticals (VRTX) closed the most recent trading day at $397.70, moving -0.76% from the...
Cwm LLC Purchases 190 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
ETF DAILY NEWS· 6 days agoCwm LLC grew its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 3.5% during the 4th quarter, according to its ...
Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 days agoVertex Pharmaceuticals Incorporated VRTX is scheduled to release first-quarter 2024 results on May...
EU expands cystic fibrosis treatment for infants with KALYDECO By Investing.com
Investing.com· 6 days agoVertex Pharmaceuticals (NASDAQ:VRTX) has announced the European Commission's approval to expand the...
(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest By Benzinga
Investing.com· 7 days agoVertex Pharmaceuticals's (NYSE:VRTX) short percent of float has fallen 3.75% since its last report....
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
Zacks via Yahoo Finance· 3 days agoVertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings...
...Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs - Vertex ...
Benzinga· 6 days agoVertex Pharmaceuticals Inc‘s VRTX blockbuster drug Trikafta for cystic fibrosis (CF) has shown remarkable efficacy, potentially extending the lives of some ...
Ad
related to: vertex pharmaceuticals